Cargando…

Adjuvant radiotherapy, chemotherapy or surgery alone for high‐risk histological node negative esophageal squamous cell carcinoma: Protocol for a multicenter prospective randomized controlled trial

Histologically node negative esophageal squamous cell carcinoma (pN0 ESCC) after radical resection still carries a significant risk of recurrence, especially in high‐risk patients. Our previous study showed that the risk of recurrence was associated with tumor location and cell differentiation, as w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Xufeng, Fang, Wentao, Li, Zhigang, Yu, Zhengtao, Rong, Tiehua, Fu, Jianhua, Han, Yongtao, Tan, Lijie, Chen, Chun, Liu, Shuoyan, Liao, Yongde, Xiao, Gaoming, Wei, Yucheng, Zhu, Chengchu, Li, Hecheng, Luo, Jinhua, Xing, Wenqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2018
Materias:	Study Protocols
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275834/ https://www.ncbi.nlm.nih.gov/pubmed/30276974 http://dx.doi.org/10.1111/1759-7714.12882

Ejemplares similares

The Role of Adjuvant Chemotherapy in the Treatment of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemotherapy
por: Li, Keting, et al.
Publicado: (2023)

Pelvic lymph node dissection alone versus adjuvant radiotherapy in node positive penile cancer: A systematic review
por: Naushad, Naufa, et al.
Publicado: (2022)

Adjuvant endocrine therapy alone in patients with node-positive, luminal A type breast cancer
por: Park, Sungmin, et al.
Publicado: (2017)

The impact of adjuvant therapy on survival for node-negative esophageal squamous cell carcinoma: a propensity score-matched analysis
por: Deng, Xuyang, et al.
Publicado: (2021)

Proposed modifications of supraclavicular lymph node metastasis in the esophageal squamous cell carcinoma staging system for improved survival stratification
por: Zheng, Yuzhen, et al.
Publicado: (2017)

Robot-assisted esophagectomy (RAE) versus conventional minimally invasive esophagectomy (MIE) for resectable esophageal squamous cell carcinoma: protocol for a multicenter prospective randomized controlled trial (RAMIE trial, robot-assisted minimally invasive Esophagectomy)
por: Yang, Yang, et al.
Publicado: (2019)

Editorial: Surgical Selection of Sublobar Resection and Scope of Lymph Node Dissection for Early-Stage Lung Cancer
por: Sun, Jiajing, et al.
Publicado: (2022)

Right versus left transthoracic approach for lymph node-negative esophageal squamous cell carcinoma
por: Ma, Qilong, et al.
Publicado: (2015)

Postoperative adjuvant chemotherapy versus chemoradiotherapy for node-positive esophageal squamous cell carcinoma: a propensity score-matched analysis
por: Wang, Qifeng, et al.
Publicado: (2020)

PD‐1/PD‐L1 based immunochemotherapy versus chemotherapy alone for advanced esophageal squamous cell carcinoma: A meta‐analysis focus on PD‐L1 expression level
por: Jin, Zixian, et al.
Publicado: (2023)

Comparisons of histological features among primary oral squamous cell carcinomas before and after adjuvant chemotherapy and their lymph node metastatic cancer lesions after adjuvant chemotherapy
por: Cheng, Feng-Chou, et al.
Publicado: (2022)

Efficacy of adjuvant chemotherapy on overall survival in patients with lymph node‐positive esophageal squamous cell carcinoma: Is oral chemotherapy promising?
por: Fang, Shuogui, et al.
Publicado: (2022)

Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma: The NEOCRTEC(50)10 Randomized Clinical Trial
por: Yang, Hong, et al.
Publicado: (2021)

Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial
por: Yang, Hong, et al.
Publicado: (2018)

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for clinical node‐negative esophageal carcinoma
por: Gao, Hui‐Jiang, et al.
Publicado: (2020)

POSNOC—POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes
por: Goyal, Amit, et al.
Publicado: (2021)

Minimally invasive esophagectomy for esophageal cancer in the People’s Republic of China: an overview
por: Zhu, Chengchu, et al.
Publicado: (2013)

SUCCOR Nodes: May Sentinel Node Biopsy Determine the Need for Adjuvant Treatment?
por: Berasaluce Gómez, Arantxa, et al.
Publicado: (2023)

Endoscopic resection with adjuvant treatment versus esophagectomy for early-stage esophageal cancer
por: Huang, Binhao, et al.
Publicado: (2021)

The Notch1 gene may control cell chemoresistance in esophageal squamous cell cancer
por: Gao, Kun, et al.
Publicado: (2021)

Preemptive analgesia in the “non-tube no fasting” fast track program for resectable esophageal carcinoma
por: Liu, Xianben, et al.
Publicado: (2022)

Adjuvant chemotherapy in node‐positive patients after esophagectomy for esophageal squamous cell carcinoma
por: Jeon, Yeong Jeong, et al.
Publicado: (2023)

Neoadjuvant therapy with immunoagent (nivolumab) or placebo plus chemotherapy followed by surgery and adjuvant treatment in subjects with resectable esophageal squamous cell carcinoma: study protocol of a randomized, multicenter, double blind, phase II trial (NATION-2203 trial)
por: Yin, Jun, et al.
Publicado: (2023)

Histology of metastatic colorectal cancer in a lymph node
por: Yokoyama, Shozo, et al.
Publicado: (2023)

Knockdown of lncRNA XIST Suppresses Cell Tumorigenicity in Human Non-Small Cell Lung Cancer by Regulating miR-142-5p/PAX6 Axis
por: Jiang, Qingfeng, et al.
Publicado: (2020)

Long Non-Coding RNA TP73-AS1 Promotes the Development of Lung Cancer by Targeting the miR-27b-3p/LAPTM4B Axis
por: Jiang, Qingfeng, et al.
Publicado: (2020)

Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer
por: Horii, R, et al.
Publicado: (2007)

Adjuvant Radiochemotherapy versus Chemotherapy Alone for Gastric Cancer: Implications for Target Definition
por: Xu, Jing, et al.
Publicado: (2019)

The feasibility of a “no tube, no fasting” fast-track recovery protocol after esophagectomy for esophageal cancer patients aged 75 and over
por: Xing, Wenqun, et al.
Publicado: (2023)

Sentinel Node Biopsy Alone versus Completion Axillary Node Dissection in Node Positive Breast Cancer: Systematic Review and Meta-Analysis
por: Ram, Rachna, et al.
Publicado: (2014)

The role of ferroptosis in esophageal cancer
por: Wang, Zimin, et al.
Publicado: (2022)

Characteristics of lymph node metastasis in resected adenosquamous lung cancer
por: Kong, Min, et al.
Publicado: (2017)

Adjuvant chemotherapy with paclitaxel and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma
por: Zhang, Liangze, et al.
Publicado: (2017)

Ultrasound findings and histological features of ductal carcinoma in situ detected by ultrasound examination alone
por: Izumori, Ayumi, et al.
Publicado: (2009)

Association of survival with adjuvant radiotherapy for pN0 esophageal cancer
por: Gao, Huijiang, et al.
Publicado: (2023)

A prognostic score in histological node negative breast cancer.
por: Chevallier, B., et al.
Publicado: (1990)

The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma
por: Zheng, Yan, et al.
Publicado: (2022)

Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer - a prospective study
por: Chintamani, et al.
Publicado: (2011)

Lymph Node Number Predicts the Efficacy of Adjuvant Chemoradiotherapy in Node-Positive Endometrial Cancer Patients
por: Lee, Jie, et al.
Publicado: (2020)

Adjuvant Radiation Therapy Alone for HPV Related Oropharyngeal Cancers with High Risk Features
por: Su, William, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_a4p8fp3cehhav05ueg7v84kh9h